Literature DB >> 12547233

Dominant hemochromatosis due to N144H mutation of SLC11A3: clinical and biological characteristics.

Omer T Njajou1, Gerard de Jong, Bianca Berghuis, Norbert Vaessen, Pieter J L M Snijders, Jan P Goossens, John H P Wilson, Martijn H Breuning, Ben A Oostra, Peter Heutink, Lodewijk A Sandkuijl, Cornelia M van Duijn.   

Abstract

Hereditary hemochromatosis is classically inherited as a recessive trait but is genetically heterogeneous. Mutations in the HFE and the TFR2 genes account for about 80% of patients and a third locus on chromosome 1q is responsible for juvenile hemochromatosis. We describe here the clinical and biological characteristics of autosomal dominant form of iron overload due to the N144H mutation of the SLC11A3 gene. Clinical signs of iron overload in patients include joint pains, cardiomyopathies, liver fibrosis and hormonal disorders including diabetes mellitus. The main and most common clinical symptoms in this family were joint complaints and early signs of arthrosis. Serum ferritin levels in iron overloaded subjects varied from 31 to 2179 ng/ml and the transferrin saturation from 13 to 88.6%. The iron overload is moderate compared to patients with type 1 hemochromatosis but the deferoxamine test was normal in all patients. The disease in this family segregated as a dominant trait. None of the patients was homozygous or compound heterozygous for any known mutation in the HFE or TFR2 genes. The disease in this family represents a non-classical form of iron overload caused by the N144H mutation in the SLC11A3 gene. The reports of other distinct mutations in SLC11A3 suggest that this gene may be of interest for further etiologic research.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12547233     DOI: 10.1006/bcmd.2002.0581

Source DB:  PubMed          Journal:  Blood Cells Mol Dis        ISSN: 1079-9796            Impact factor:   3.039


  11 in total

1.  A male patient with ferroportin disease B and a female patient with iron overload similar to ferroportin disease B.

Authors:  Tetsuji Yamashita; Natsuko Morotomi; Tetsuro Sohda; Hisao Hayashi; Naohiko Yoshida; Keiko Ochi; Izumi Ohkura; Mika Karita; Hiroko Fujiwara; Haruhiko Yamashita; Ai Hattori; Yasuaki Tatsumi
Journal:  Clin J Gastroenterol       Date:  2014-04-19

2.  The molecular basis of ferroportin-linked hemochromatosis.

Authors:  Ivana De Domenico; Diane McVey Ward; Elizabeta Nemeth; Michael B Vaughn; Giovanni Musci; Tomas Ganz; Jerry Kaplan
Journal:  Proc Natl Acad Sci U S A       Date:  2005-06-13       Impact factor: 11.205

3.  A mouse model of juvenile hemochromatosis.

Authors:  Franklin W Huang; Jack L Pinkus; Geraldine S Pinkus; Mark D Fleming; Nancy C Andrews
Journal:  J Clin Invest       Date:  2005-08       Impact factor: 14.808

Review 4.  Endocrine dysfunction in hereditary hemochromatosis.

Authors:  C Pelusi; D I Gasparini; N Bianchi; R Pasquali
Journal:  J Endocrinol Invest       Date:  2016-03-07       Impact factor: 4.256

5.  The hepcidin-binding site on ferroportin is evolutionarily conserved.

Authors:  Ivana De Domenico; Elizabeta Nemeth; Jenifer M Nelson; John D Phillips; Richard S Ajioka; Michael S Kay; James P Kushner; Tomas Ganz; Diane M Ward; Jerry Kaplan
Journal:  Cell Metab       Date:  2008-08       Impact factor: 27.287

6.  Investigation of the biophysical and cell biological properties of ferroportin, a multipass integral membrane protein iron exporter.

Authors:  Adrian E Rice; Michael J Mendez; Craig A Hokanson; Douglas C Rees; Pamela J Björkman
Journal:  J Mol Biol       Date:  2009-01-03       Impact factor: 5.469

7.  Molecular and clinical correlates in iron overload associated with mutations in ferroportin.

Authors:  Ivana De Domenico; Diane McVey Ward; Elizabeta Nemeth; Tomas Ganz; Elena Corradini; Francesca Ferrara; Giovanni Musci; Antonello Pietrangelo; Jerry Kaplan
Journal:  Haematologica       Date:  2006-08       Impact factor: 9.941

8.  Ferroportin disease: a systematic meta-analysis of clinical and molecular findings.

Authors:  Roman Mayr; Andreas R Janecke; Melanie Schranz; William J H Griffiths; Wolfgang Vogel; Antonello Pietrangelo; Heinz Zoller
Journal:  J Hepatol       Date:  2010-07-17       Impact factor: 25.083

9.  Ferroportin disease mutations influence manganese accumulation and cytotoxicity.

Authors:  Eun-Kyung Choi; Trang-Tiffany Nguyen; Shigeki Iwase; Young Ah Seo
Journal:  FASEB J       Date:  2018-09-24       Impact factor: 5.834

10.  Effect of Nerium oleander (N.O.) leaves extract on serum hepcidin, total iron, and infiltration of ED1 positive cells in albino rat.

Authors:  Muddasir Hassan Abbasi; Sana Fatima; Naila Naz; Ihtzaz A Malik; Nadeem Sheikh
Journal:  Biomed Res Int       Date:  2013-08-31       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.